Heparanase expression in head and neck squamous cell carcinomas is associated with reduced proliferation and improved survival

Histopathology

Volumn 58, Issue 6, 2011, Pages 944-952

  Mogler, Carolin ^a   Herold Mende, Christel ^b,c   Dyckhoff, Gerhard ^c   Jenetzky, Ekkehart ^d   Beckhove, Philipp ^d   Helmke, Burkhard M ^a  

^a Elbeklinikum Stade   (Germany)

^b Division of Neurosurgical Research   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Head and neck squamous cell carcinoma; Heparanase; Proliferation; Survival

Indexed keywords

HEPARANASE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER STAGING; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; FEMALE; FOLLOW-UP STUDIES; GLUCURONIDASE; HEAD AND NECK NEOPLASMS; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 79956073069     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03834.x     Document Type: Article

References (46)

1. Simizu S, Ishida K, Wierzba MK et al. Expression of heparanase in human tumor cell lines and human head and neck tumors. Cancer Lett. 2003; 193; 83-89.
2. Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 2007; 18; 581-592.
3. Dunne AA, Muller HH, Eisele DW et al. Meta-analysis of the prognostic significance of perinodal spread in head and neck squamous cell carcinoma (HNSCC) patients. Eur. J. Cancer 2006; 42; 1863-1868.
4. Vlodavsky I, Michaeli RI, Bar-Ner M et al. Involvement of heparanase in tumor metastasis and angiogenesis. Isr. J. Med. Sci. 1988; 24; 464-470.
5. Vlodavsky I, Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J. Clin. Invest. 2001; 108; 341-347.
6. Wight TN, Kinsella MG, Qwarnstrom EE. The role of proteoglycans in cell adhesion, migration and proliferation. Curr. Opin. Cell Biol. 1992; 4; 793-801.
7. Vlodavsky I, Goldshmidt O, Zcharia E et al. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin. Cancer Biol. 2002; 12; 121-129.
8. Vlodavsky I, Goldshmidt O. Properties and function of heparanase in cancer metastasis and angiogenesis. Haemostasis 2001; 31(Suppl. 1); 60-63.
9. Vlodavsky I, Goldshmidt O, Zcharia E et al. Molecular properties and involvement of heparanase in cancer progression and normal development. Biochimie 2001; 83; 831-839.
10. Goldshmidt O, Zcharia E, Cohen M et al. Heparanase mediates cell adhesion independent of its enzymatic activity. FASEB J. 2003; 17; 1015-1025.
11. Bar-Ner M, Mayer M, Schirrmacher V et al. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix. J. Cell. Physiol. 1986; 128; 299-306.
12. Hulett MD, Freeman C, Hamdorf BJ et al. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat. Med. 1999; 5; 803-809.
13. McKenzie E, Tyson K, Stamps A et al. Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem. Biophys. Res. Commun. 2000; 276; 1170-1177.
14. Friedmann Y, Vlodavsky I, Aingorn H et al. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am. J. Pathol. 2000; 157; 1167-1175.
15. Ginath S, Menczer J, Friedmann Y et al. Expression of heparanase, Mdm2, and erbB2 in ovarian cancer. Int. J. Oncol. 2001; 18; 1133-1144.
16. Gohji K, Okamoto M, Kitazawa S et al. Heparanase protein and gene expression in bladder cancer. J. Urol. 2001; 166; 1286-1290.
17. Shinyo Y, Kodama J, Hongo A et al. Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer. Ann. Oncol. 2003; 14; 1505-1510.
18. Maxhimer JB, Quiros RM, Stewart R et al. Heparanase-1 expression is associated with the metastatic potential of breast cancer. Surgery 2002; 132; 326-333.
19. Kosir MA, Quinn CC, Zukowski KL et al. Human prostate carcinoma cells produce extracellular heparanase. J. Surg. Res. 1997; 67; 98-105.
20. Davidson B, Shafat I, Risberg B et al. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma. Gynecol. Oncol. 2007; 104; 311-319.
21. Kim AW, Xu X, Hollinger EF et al. Human heparanase-1 gene expression in pancreatic adenocarcinoma. J. Gastrointest. Surg. 2002; 6; 167-172.
22. Koliopanos A, Friess H, Kleeff J et al. Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res. 2001; 61; 4655-4659.
23. Chen XP, Liu YB, Rui J et al. Heparanase mRNA expression and point mutation in hepatocellular carcinoma. World J. Gastroenterol. 2004; 10; 2795-2799.
24. Okawa T, Naomoto Y, Nobuhisa T et al. Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2. Clin. Cancer Res. 2005; 11; 7995-8005.
25. Tang W, Nakamura Y, Tsujimoto M et al. Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma. Mod. Pathol. 2002; 15; 593-598.
26. Beckhove P, Helmke BM, Ziouta Y et al. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis. Clin. Cancer Res. 2005; 11; 2899-2906.
27. Doweck I, Kaplan-Cohen V, Naroditsky I et al. Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival. Neoplasia 2006; 8; 1055-1061.
28. Dempsey LA, Brunn GJ, Platt JL. Heparanase, a potential regulator of cell-matrix interactions. Trends Biochem. Sci. 2000; 25; 349-351.
29. Goldshmidt O, Zcharia E, Abramovitch R et al. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc. Natl. Acad. Sci. USA 2002; 99; 10031-10036.
30. Parish CR, Freeman C, Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biochim. Biophys. Acta 2001; 1471; M99-M108.
31. Vlodavsky I, Friedmann Y, Elkin M et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat. Med. 1999; 5; 793-802.
32. Dutta U, Poornachandra KS. Heparanase and gallbladder cancer: new insights into understanding tumor growth and invasion. J. Gastroenterol. Hepatol. 2008; 23; 343-344.
33. Bar-Sela G, Kaplan-Cohen V, Ilan N et al. Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival. Histopathology 2006; 49; 188-193.
34. Quiros RM, Rao G, Plate J et al. Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival. Cancer 2006; 106; 532-540.
35. Rohloff J, Zinke J, Schoppmeyer K et al. Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Br. J. Cancer 2002; 86; 1270-1275.
36. Fux L, Ilan N, Sanderson RD et al. Heparanase: busy at the cell surface. Trends Biochem. Sci. 2009; 34; 511-519.
37. Schubert SY, Ilan N, Shushy M et al. Human heparanase nuclear localization and enzymatic activity. Lab. Invest. 2004; 84; 535-544.
38. Benhamron S, Nechushtan H, Verbovetski I et al. Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells. J. Immunol. 2006; 176; 6417-6424.
39. Nobuhisa T, Naomoto Y, Okawa T et al. Translocation of heparanase into nucleus results in cell differentiation. Cancer Sci. 2007; 98; 535-540.
40. Nobuhisa T, Naomoto Y, Takaoka M et al. Emergence of nuclear heparanase induces differentiation of human mammary cancer cells. Biochem. Biophys. Res. Commun. 2005; 331; 175-180.
41. Wang Z, Xu H, Jiang L et al. Positive association of heparanase expression with tumor invasion and lymphatic metastasis in gastric carcinoma. Mod. Pathol. 2005; 18; 205-211.
42. Zhang YL, Fu ZR, Zhang J et al. Inhibition of invasiveness of human mammary carcinoma cell line MDA435 by heparanase antisense oligodeoxynucleotide. Zhonghua Yi Xue Za Zhi 2003; 83; 204-207.
43. Zhou Y, Song B, Qin WJ et al. Heparanase promotes bone destruction and invasiveness in prostate cancer. Cancer Lett. 2008; 268; 252-259.
44. Zheng LD, Jiang GS, Pu JR et al. Stable knockdown of heparanase expression in gastric cancer cells invitro. World J. Gastroenterol. 2009; 15; 5442-5448.
45. Gingis-Velitski S, Zetser A, Flugelman MY et al. Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J. Biol. Chem. 2004; 279; 23536-23541.
46. Zetser A, Bashenko Y, Miao HQ et al. Heparanase affects adhesive and tumorigenic potential of human glioma cells. Cancer Res. 2003; 63; 7733-7741.